| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
7,182,377 | 5,974,753 | 4,246,703 | 3,199,921 | 4,650,737 |
| Cost of Revenue
|
-4,767,132 | -4,327,834 | -3,632,903 | -3,212,151 | -3,814,101 |
|
Gross Profit
|
2,415,245 | 1,646,919 | 613,800 | -12,230 | 836,636 |
| Selling, General and Administrative Expenses
|
-774,267 | -595,566 | -475,820 | -453,618 | -566,794 |
|
Research and Development Expenses
|
-233,140 | -118,853 | -47,824 | -56,890 | -46,677 |
|
Operating Income/Expenses
|
-1,007,407 | -714,419 | -523,644 | -510,508 | -613,471 |
|
Total Operating Profit/Loss
|
1,407,838 | 932,500 | 90,156 | -522,738 | 223,165 |
| Total Net Finance Income/Expense
|
-163,409 | -177,542 | -176,326 | -151,106 | -122,987 |
| Net Investment Income
|
395 | 873 | 1,985 | 1,156 | 1,585 |
|
Other Income/Expense, Non-Operating
|
1,108,237 | 279,488 | 139,515 | -169,938 | -46,202 |
|
Non-Operating Income/Expenses, Total
|
945,223 | 102,819 | -34,826 | -319,888 | -167,604 |
|
Pretax Income
|
2,353,061 | 1,035,319 | 55,330 | -842,626 | 55,561 |
|
Provision for Income Tax
|
-333,799 | -178,778 | 7,556 | 191,431 | -24,038 |
|
Net Income from Continuing Operations
|
2,019,262 | 856,541 | 62,886 | -651,195 | 31,523 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
2,019,262 | 856,541 | 62,886 | -651,195 | 31,523 |
|
Net Income after Non-Controlling/Minority Interests
|
2,019,262 | 856,541 | 62,886 | -651,195 | 31,523 |
|
Net Income Available to Common Stockholders
|
2,019,262 | 856,541 | 62,886 | -651,195 | 31,523 |
|
Diluted Net Income Available to Common Stockholders
|
2,019,262 | 856,541 | 62,886 | -651,195 | 31,523 |
| Basic EPS
|
3.44 | 1.56 | 0.12 | -1.35 | 0.06 |
| Diluted EPS
|
3.43 | 1.56 | 0.12 | -1.35 | 0.06 |
|
Basic Weighted Average Shares Outstanding
|
585,363.48 | 548,396.12 | 507,927.53 | 480,634.25 | 486,150.95 |
|
Diluted Weighted Average Shares Outstanding
|
585,363.48 | 548,396.12 | 507,927.53 | 480,634.25 | 486,150.95 |
|
EBIT
|
2,516,470 | 1,212,861 | 231,656 | -691,520 | 178,548 |
|
EBITDA
|
3,584,507 | 2,140,626 | 947,931 | 13,976 | 924,939 |
|
Normalized EBITDA
|
2,506,600 | 1,978,466 | 825,569 | 272,713 | 1,134,050 |
|
Normalized Income
|
1,094,263.65 | 722,382.63 | -35,003.60 | -451,238.91 | 198,811.80 |
|
Total Unusual Items
|
-1,077,907 | -162,160 | -122,362 | 258,737 | 209,111 |
|
Total Unusual Items Excluding Goodwill
|
-1,077,907 | -162,160 | -122,362 | 258,737 | 209,111 |
|
Tax Effect of Unusual Items
|
-152,908.65 | -28,001.63 | -24,472.40 | 58,780.91 | 41,822.20 |
|
Tax Rate, Calculated
|
0.14 | 0.17 | 0.20 | 0.23 | 0.20 |
12/31/2022 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade